Research Projects

Coumarin, a naturally occurring compound, is known for its anticancer activity, which has been extensively studied for its potential to inhibit tumor growth, induce apoptosis, and modulate cellular signaling pathways involved in cancer progression. Cancer is a leading cause of death, with genetic inheritance and exposure to carcinogens being significant contributors. Tobacco usage alone accounts for approximately 22% of cancer-related deaths. Cancer medications have been discovered, but they often come with severe side effects due to their targeting of rapidly dividing cells. Prostate and breast cancer are two of the most common types of cancer worldwide, with significant morbidity and mortality rates. There is an urgent need for efficient cancer treatments that minimize adverse reactions. A project focusing on prostate and breast cancer aims to identify specific targets and pathways involved in cell growth and survival by investigating the molecular mechanisms underlying the anticancer activity of coumarin hybrid heterocyclic compounds. Designing coumarin hybrid heterocyclic compounds involves combining the structural features and pharmacological properties of coumarin with other heterocyclic frameworks, offering the opportunity to create novel chemical entities with enhanced biological activity, improved drug-like properties, and specific targeting potential against these cancers. This approach provides a detailed understanding of the compounds' biological activity and helps optimize their efficacy and selectivity. In conclusion, the scientific rationale for the project lies in the potential of coumarin hybrid heterocyclic compounds as novel anticancer agents against prostate and breast cancer.